Stocktoria
Cuprina Holdings (Cayman) LTD CUPR
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2025-04-10
Cuprina Holdings (Cayman) LTD financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $38,789 | $35,522 | $100,773 |
| Gross profit | -$501 | -$2,223 | $36,605 |
| R&D expense | $176,385 | $177,433 | $177,433 |
| SG&A expense | $3.6M | $1.0M | $937,200 |
| Operating income | -$3.8M | -$1.2M | -$1.1M |
| Interest expense | $11,447 | $1,311 | $727 |
| Net income | -$3.6M | -$1.1M | -$1.1M |
| EPS (diluted) | $-17.75 | $-6.38 | $-6.22 |
| Operating cash flow | -$7.1M | -$908,609 | -$894,981 |
| Free cash flow | -$7.1M | -$924,697 | -$962,958 |
| Cash & equivalents | $2.4M | $85,622 | $35,263 |
| Inventory | — | $1,272 | $7,665 |
| Total assets | $6.6M | $1.3M | $1.6M |
| Total liabilities | $2.7M | $4.6M | $4.5M |
| Shareholders' equity | $3.9M | -$3.3M | -$3.3M |
Growth · year-over-year · Revenue CAGR -38%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +9.2% | -64.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.